创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

Advanced Search

column
The Role of Methionine Adenosyltransferase 2A in Tumorigenesis and the Development of Its Inhibitors
WANG Pengfei, CHEN Yi
2022, 46(12): 884-897. DOI: 10.20053/j.issn1001-5094.2022.12.002
Abstract PDF
Research Progress of New Targets and Strategies to Regulate Proteostasis in Cancer
YUAN Tao, QIAN Meijia, GE Fujing, DU Jiamin, WANG Jiao, YAN Fangjie, ZHU Hong, YANG Bo
2022, 46(12): 898-909. DOI: 10.20053/j.issn1001-5094.2022.12.003
Abstract PDF
Research Progress of Immune Checkpoint Inhibitors
ZHANG Wenxin, GUO Hongjie, PAN Xiaohui, CHEN Xi, TAO Quanwei, WU Honghai, DING Ling
2022, 46(12): 910-921. DOI: 10.20053/j.issn1001-5094.2022.12.004
Abstract PDF
Advances in Targeted Therapies for Pediatric Tumors
CHEN Yifan, LIU Runzhi, WANG Jinhu, XU Xiaojun, CAO Ji, YING Meidan
2022, 46(12): 922-936. DOI: 10.20053/j.issn1001-5094.2022.12.005
Abstract PDF
Progress of Research on the Role and Mechanism of Autophagy in the Toxicity of Anti-Tumor Drugs
CHEN Jian, ZENG Yan, GAO Zizheng, HU Yuhuai, YAN Hao, XU Zhifei, LUO Peihua, YANG Bo, HE Qiaojun
2022, 46(12): 937-950. DOI: 10.20053/j.issn1001-5094.2022.12.006
Abstract PDF
Progress of Research on the Mechanism of Action of Traditional Chinese Medicine Monomers in Prostate Cancer Intervention
WANG Huating, YU Caini, KANG Yuanyuan, LI Dan
2022, 46(12): 951-960. DOI: 10.20053/j.issn1001-5094.2022.12.007
Abstract PDF